跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
LAMOTRIGINE -WGR lamotrigine 25 mg dispersible/chewable tablet blister pack
Approved
STANDARD
LAMOTRIGINE -WGR lamotrigine 25 mg dispersible/chewable tablet blister pack
GM Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
691b6d3cdb7d1041
Company
GM Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
691b6d3cdb7d1041
Product Name
LAMOTRIGINE -WGR lamotrigine 25 mg dispersible/chewable tablet blister pack
Artg Id
340911
Artg Name
LAMOTRIGINE-WGR lamotrigine 25 mg dispersible/chewable tablet blister pack
Sponsor
GM Pharma International Pty Ltd
Company Detail Path
/organization/gm-pharma-international-pty-ltd
Artg Date
2020-08-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fa35282afd551703446caa23a011602b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/13055bdd793b4f6e2c0eaa969635428f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
691b6d3cdb7d1041
Type
Standard
Back to TGA Approvals
LAMOTRIGINE -WGR lamotrigine 25 mg dispersible/chewable tablet blister pack - TGA Drug Approval Details
